Today's Health News

Neoadjuvant Novel Hormonal Agents Studied in High-Risk Prostate Cancer

Neoadjuvant therapy with an NHA associated with longer time to biochemical recurrence, prolonged metastasis-free survival

Coffee Intake Linked to Longer Prostate Cancer-Specific Survival

Longer prostate cancer-specific survival seen for specific subgroups, including those with the CYP1A2 AA genotype

Medical Debt Tied to Worsening of Food, Housing Insecurity

Risk factors for medical indebtedness include hospitalization, disability, high deductible, Medicare Advantage, and no insurance coverage

Erectile Function Mostly Not Impacted by Surgery for BPH

But rate of retrograde ejaculation higher following many surgical procedures for benign prostatic hyperplasia

Self-Cut Mesh Noninferior for Pelvic Organ Prolapse Procedure

Surgical success rate for self-cut mesh noninferior to that for commercial mesh kit with benefit of cost savings

Physician Burnout May Raise Risk for Patient Safety Events

Burnout also associated with decreased job satisfaction, low professionalism, patient dissatisfaction

Adjuvant Nivolumab + Ipilimumab Lacks Efficacy for Localized RCC

Trial did not meet primary efficacy end point of disease-free survival in patients with localized RCC at high risk for postnephrectomy relapse

Biden Makes Another Push for Cancer Moonshot Initiative

President likened JFK's space race to his own effort to slash cancer rates by 50 percent in the next 25 years

Summary Elixhauser Comorbidity Score Developed for Use in Older Adults

Unclear whether the S-Elixhauser comorbidity score offers an advantage over other similar measures

OOP Costs for Cancer Treatments Increased From 2009 to 2016

Total costs increased for breast, lung, prostate cancer; OOP costs increased for these cancers and colorectal cancer